Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib or Temsirolimus in Advanced Rare Tumours
NCT01396408Phase 2Active, not recruiting
- Sponsor
- Canadian Cancer Trials Group
- Start
- Feb 2012
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib, temsirolimus, sponsored by Canadian Cancer Trials Group. Started Feb 2012; status: active, not recruiting.
02
Drugs
sunitinibtemsirolimus
Beyond the preview
Go deeper on NCT01396408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396408.